🇺🇸 FDA
Patent

US 8728524

Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

granted A61KA61K31/715A61K31/728

Quick answer

US patent 8728524 (Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions) held by Anika Therapeutics S.r.l. expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Anika Therapeutics S.r.l.
Grant date
Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/715, A61K31/728, A61K31/737, A61K31/795